Catalyst Pharmaceuticals Inc - Strategy, SWOT and Corporate Finance Report

Catalyst Pharmaceuticals Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Catalyst Pharmaceuticals Inc (Catalyst) is a biopharmaceutical company that develops prescription drugs targeting rare neurological and neuromuscular diseases. The company focuses on specific conditions such as infantile spasms, complex partial seizures, Lambert-Eaton myasthenic syndrome (LEMS), congenital myasthenic syndromes (CMS), downbeat nystagmus and Tourette syndrome. Its product portfolio includes Firdapse, a proprietary form of amifampridine phosphate for the treatment of LEMS, CMS and myasthenia gravis; CPP-115, a GABA aminotransferase inhibitor for central nervous system (CNS) indications, such as infantile spasms, epilepsy and Tourette syndrome; and CPP-109, a generic version of Sabril for Tourette’s disorder. The company operates in the US and through its subsidiary in Ireland. Catalyst is headquartered in Coral Gables, Florida, the US.

Scope

  • Detailed information on Catalyst Pharmaceuticals Inc required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Catalyst Pharmaceuticals Inc in the form of a SWOT analysis
  • An in-depth view of the business model of Catalyst Pharmaceuticals Inc including a breakdown and examination of key business segments
  • News about Catalyst Pharmaceuticals Inc, such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

  • Gain understanding of Catalyst Pharmaceuticals Inc and the factors that influence its strategies.
  • Track strategic initiatives of the company and latest corporate news and actions.
  • Assess Catalyst Pharmaceuticals Inc as a prospective partner, vendor or supplier.
  • Support sales activities by understanding your customers' businesses better.
  • Stay up to date on Catalyst Pharmaceuticals Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

ReceptoPharm Inc

Psyadon Pharmaceuticals Inc

Marinus Pharmaceuticals Inc

Marathon Pharmaceuticals LLC

Jacobus Pharmaceutical Co Inc

GlaxoSmithKline Plc

ReceptoPharm Inc

Psyadon Pharmaceuticals Inc

Marinus Pharmaceuticals Inc

Marathon Pharmaceuticals LLC

Jacobus Pharmaceutical Co Inc

GlaxoSmithKline Plc

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Catalyst Pharmaceuticals Inc - Key Facts

Catalyst ...

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Catalyst Pharmaceuticals Inc - Key Facts

Catalyst Pharmaceuticals Inc - Key Employees

Catalyst Pharmaceuticals Inc - Key Employee Biographies

Catalyst Pharmaceuticals Inc - Major Products and Services

Catalyst Pharmaceuticals Inc - History

Catalyst Pharmaceuticals Inc - Company Statement

Catalyst Pharmaceuticals Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Catalyst Pharmaceuticals Inc - Business Description

Catalyst Pharmaceuticals Inc - Corporate Strategy

Catalyst Pharmaceuticals Inc - SWOT Analysis

SWOT Analysis - Overview

Catalyst Pharmaceuticals Inc - Strengths

Catalyst Pharmaceuticals Inc - Weaknesses

Catalyst Pharmaceuticals Inc - Opportunities

Catalyst Pharmaceuticals Inc - Threats

Catalyst Pharmaceuticals Inc - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Catalyst Pharmaceuticals Inc, Recent Deals Summary

Section 5 – Company’s Recent Developments

Aug 07, 2019: Catalyst Pharmaceuticals announces second quarter 2019 financial results and provides corporate update

May 13, 2019: Catalyst Pharmaceuticals announces first quarter 2019 financial results and provides corporate updatea

Mar 18, 2019: Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Update

Feb 05, 2019: US Senate invites seven pharma majors to testify on price hikes

Nov 07, 2018: Catalyst Pharmaceuticals announces third quarter 2018 financial results and provides corporate update

Aug 20, 2018: Catalyst Pharmaceuticals names Dr. Stanley Iyadurai as vice president of clinical development

Aug 07, 2018: Catalyst Pharmaceuticals Announces Second Quarter 2018 Financial Results and Provides Corporate Update

Aug 06, 2018: Catalyst Pharmaceuticals expands commercial leadership team

May 23, 2018: CENTOGENE Announces Drug Development Collaboration with Orphazyme in Neuronopathic Gaucher Disease

May 09, 2018: Catalyst Pharmaceuticals Announces First Quarter 2018 Financial Results and Provides Corporate Update

Section 6 – Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

List of Tables

List of Tables

Catalyst Pharmaceuticals Inc, Key Facts

Catalyst Pharmaceuticals Inc, Key Employees

Catalyst Pharmaceuticals Inc, Key Employee Biographies

Catalyst Pharmaceuticals Inc, Major Products and ...

List of Tables

Catalyst Pharmaceuticals Inc, Key Facts

Catalyst Pharmaceuticals Inc, Key Employees

Catalyst Pharmaceuticals Inc, Key Employee Biographies

Catalyst Pharmaceuticals Inc, Major Products and Services

Catalyst Pharmaceuticals Inc, History

Catalyst Pharmaceuticals Inc, Subsidiaries

Catalyst Pharmaceuticals Inc, Key Competitors

Catalyst Pharmaceuticals Inc, Ratios based on current share price

Catalyst Pharmaceuticals Inc, Annual Ratios

Catalyst Pharmaceuticals Inc, Annual Ratios (Cont...1)

Catalyst Pharmaceuticals Inc, Interim Ratios

Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Catalyst Pharmaceuticals Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Catalyst Pharmaceuticals Inc, Performance Chart (2014 - 2018)

Catalyst Pharmaceuticals Inc, Ratio Charts

Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, ...

List of Figures

Catalyst Pharmaceuticals Inc, Performance Chart (2014 - 2018)

Catalyst Pharmaceuticals Inc, Ratio Charts

Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports